Navigation Links
New Guidelines Issued for Combining HIV, Seizure Meds
Date:1/4/2012

WEDNESDAY, Jan. 4 (HealthDay News) -- Physicians need to take care when prescribing seizure medication to HIV/AIDS patients to prevent harmful interactions between drugs, experts warn.

The cautionary note from the American Academy of Neurology (AAN) has led to the issuance of a new AAN guideline, which was developed in consultation with the International League Against Epilepsy.

"It is important that patients know exactly which drugs they are taking and provide that information to all prescribing health care providers caring for them," lead guideline author Dr. Gretchen L. Birbeck, of Michigan State University in East Lansing, said in an AAN news release.

"Doctors may need to watch and adjust drug doses in people with HIV/AIDS who take seizure drugs," added Birbeck, who is also an AAN fellow.

Seizures and related disorders are not uncommon among HIV patients, according to Birbeck and colleagues. It is estimated that at least 10 percent of HIV patients experience seizures, they noted.

In the new guideline, which is published in the Jan. 4 online editions of both Neurology and Epilepsia, the research team cautioned that effectiveness of either set of drugs can be compromised when specific seizure medications are taken alongside certain HIV/AIDS treatments. Increased toxicity is another potential issue.

For example, levels of certain HIV medications -- such as phenytoin, phenobarbital and carbamazepine -- actually drop off when they come in contact with seizure drugs. The risk: an HIV drug regimen might fail, the authors pointed out.

One way Birbeck's team hopes to mitigate against such risk is to outline the correct dosages of seizure drugs. They noted that dangerous drug interactions may be avoidable if medications are prescribed in the right amounts.

The team also acknowledged that the threat of harmful drug interactions is highest where drug choices are the most curtailed. That means that patients in poorer countries, where most HIV/AIDS patients now live, are particularly vulnerable to this dynamic.

"Future research should target epilepsy and HIV/AIDS drug combinations where choices are limited, such as in developing countries, to better understand the risk of these drug interactions," Birbeck said in the news release.

More information

For more on seizures, visit the Epilepsy Foundation.

-- Alan Mozes

SOURCE: American Academy of Neurology, news release, Jan. 4, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. DMP for diabetes type 2: Current guidelines indicate some need for revision
2. CDC Issues New TB Treatment Guidelines
3. AIUM officially recognizes ACEP Emergency Ultrasound Guidelines
4. Few Contact Lens Users Follow All Care Guidelines, Study Finds
5. New Guidelines for Treating Psoriasis When Pregnant or Nursing
6. New Canadian Guidelines Also Support No Routine Mammograms Until 50
7. Canadian breast cancer screening guidelines would cost thousands of lives
8. New breast cancer screening guidelines released
9. New Stanford model establishes guidelines for earlier cancer detection
10. Few doctors follow sudden cardiac death screening guidelines for athletes
11. New Guidelines Urge Cholesterol Check for All Kids Ages 9 to 11
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Guidelines Issued for Combining HIV, Seizure Meds
(Date:12/4/2016)... ... ... Responsible dental care hinges on regular brushing of the teeth. However, just brushing ... inspired an inventor from Las Vegas, Nev., to design the BRUSH PROPER. , ... bad techniques of brushing the teeth in order to prevent cavities," he said. "Children ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... on the perils of heroin that was watched live by 1 million viewers ... I. duPont-Columbia University Award. , ASU students at the Walter Cronkite School of ...
(Date:12/2/2016)... ... 02, 2016 , ... More than 100 business, civic, community ... attend the UNCF Dothan-Wiregrass Mayor’s Luncheon Dec. 9, 2016. This inaugural event, hosted ... operating support to UNCF-member institutions, including Miles College, Oakwood University, Tuskegee University, Stillman ...
(Date:12/2/2016)... ... December 02, 2016 , ... Center for Autism and ... of those affected by autism spectrum disorder (ASD) and other developmental disabilities. The group, ... will give parents and other caregivers the opportunity to share stories and advice, seek ...
(Date:12/2/2016)... ... ... With the number of pain management programs available for people suffering with constant ... works for them. When an inventor from Suisun City, Calif., was unsuccessful in finding ... it with others. , He developed a prototype for PRO GO MASSAGE to relieve ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)... , Dec. 4, 2016 Blueprint Medicines ... discovering and developing targeted kinase medicines for patients ... its ongoing Phase 1 trial evaluating BLU-285, an ... advanced systemic mastocytosis (SM). Blueprint Medicines is developing ... D816V mutant KIT. Approximately 90 to 95 percent ...
(Date:12/4/2016)... SAN DIEGO , Dec. 3, 2016 Johnson ... filed on behalf of purchasers of Zimmer Biomet Holdings, Inc. ... September 7, 2016 through October 31, 2016 (the "Class Period"). ... It designs, manufactures, and markets orthopaedic reconstructive products, such as ... ...
(Date:12/4/2016)... NEW ORLEANS , Dec. 2, 2016  Former Attorney ... Foti, Jr., Esq. , a partner at the law firm ... has commenced an investigation into Lannett Company, Inc. (NYSE: ... Bloomberg published an article titled "U.S. Charges in ... an "antitrust investigation by the Justice Department, begun about two ...
Breaking Medicine Technology: